Drugs / Technetium-99m - Diethylenetriaminepentaacetic acid
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT07053696 | Mar → Nov 2025 | — | Andrey Petrov | Withdrawn | No outcome recorded Stop: Enrollment |
| Comparator or background therapy4 trials | ||||||
| — | NCT02450279 Comparator | Mar 2016 → Nov 2017 | — | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | Terminated | No outcome recorded |
| — | NCT02429817 Comparator | Apr 2015 → Dec 2016 | — | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | Completed | No outcome recorded |
| — | NCT02298101 Comparator | Sep 2014 → Jun 2015 | — | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | Completed | No outcome recorded |
| — | NCT01879488 Comparator | Jul 2013 → Jun 2015 | — | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 7 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Technetium-99m Diethylenetriaminepentaacetic Acid | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07053696 ↗ |
| Known as | 99mTc-DTPA | “Nebulizers were filled with diethylenetriaminepentaacetic acid labelled with technetium-99 m (99mTc-DTPA, 2 mCi/4 mL).” PMID 27822851 ↗ Nov 2016 |
| Modality | Diagnostic / imaging agent | “Pulmonary and extrapulmonary particles deposition was analyzed using planar scintigraphy.” PMID 27447788 ↗ Jul 2016 |
| Route | Inhaled | “was administrated using a vibrating-mesh nebulizer” PMID 27447788 ↗ Jul 2016 |